z-logo
Premium
A tale of two cases of pulmonary arteriovenous malformation: How they fared after cardiac transplantation
Author(s) -
Wisotzkey Bethany L.,
Magyar Dari L.,
Jones Thomas K.,
Boucek Robert J.,
Permut Lester C.,
Kemna Mariska S.,
Law Yuk M.
Publication year - 2018
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13183
Subject(s) - medicine , pulmonary artery , cardiology , hypoxemia , ventricle , right pulmonary artery , shunt (medical) , fontan procedure , left pulmonary artery , surgery
Background In single ventricle patients, aortopulmonary collaterals ( APC s) and pulmonary arteriovenous malformations ( PAVM s) following superior cavopulmonary shunt ( CPS ) can complicate orthotopic heart transplant ( OHT ) by cyanosis and hemoptysis. Although PAVM s can regress with the restoration of hepatic venous flow to the pulmonary circulation, the effects of hypoxemia on the “unconditioned” allograft are not known. Cases Two patients with significant PAVM s after CPS were cyanotic following OHT . One patient with predominantly unilateral left PAVM s had arterial saturation levels less than 70% despite pulmonary vasodilators and ventilation. A custom flow restrictor‐covered stent was deployed in the pulmonary artery of the affected side, redirecting the blood flow to the contralateral lung, immediately improving cyanosis. When the PAVM s regressed, the flow restrictor stent was dilated to eliminate the constriction. The second patient with PAVM s had cyanosis and severe hemoptysis from APC s post‐ OHT . The APC s required an extensive coil embolization, while the cyanosis responded to oxygen and pulmonary vasodilators. Both recipients did well with gradual resolution of PAVM s within 8 months. Conclusions Despite cyanosis from right‐to‐left intrapulmonary shunting, allograft function recovered. Novel transcatheter interventions can play a role in patients with significant APC s or PAVM following cardiac transplantation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom